tiprankstipranks
Trending News
More News >
Cartesian Therapeutics (RNAC)
NASDAQ:RNAC
US Market

Cartesian Therapeutics (RNAC) Income Statement

Compare
1,141 Followers

Cartesian Therapeutics Income Statement

Last quarter (Q3 2025), Cartesian Therapeutics's total revenue was $452.00K, an increase of 16.80% from the same quarter last year. In Q3, Cartesian Therapeutics's net income was $-35.90M. See Cartesian Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 38.91M$ 26.00M$ 110.78M$ 85.08M$ 16.60M
Gross Profit
$ 38.91M$ 26.00M$ 108.74M$ 85.08M$ 16.60M
Operating Expenses
$ 82.81M$ 112.42M$ 94.20M$ 89.67M$ 73.42M
Depreciation and Amortization
$ 1.15M$ 843.00K$ 2.04M$ 1.72M$ 1.73M
EBITDA
$ -75.99M$ -235.03M$ 39.84M$ -5.16M$ -65.59M
Operating Income
$ -43.90M$ -86.42M$ 14.54M$ -4.60M$ -56.82M
Other Income/Expenses
$ -33.24M$ -152.29M$ 20.23M$ -5.12M$ -12.05M
Pretax Income
$ -77.14M$ -238.71M$ 34.77M$ -9.72M$ -68.88M
Net Income
$ -77.42M$ -219.71M$ 35.38M$ -25.69M$ -68.88M
Per Share Metrics
Basic EPS
$ -2.99$ -49.76$ 7.33$ -6.74$ -20.42
Diluted EPS
$ -3.29$ -49.76$ 3.00$ -6.60$ -20.42
Weighted Average Shares Outstanding
25.91M 5.17M 4.02M 3.18M 2.81M
Weighted Average Shares Outstanding (Diluted)
23.69M 5.17M 4.05M 3.18M 2.81M
Currency in USD

Cartesian Therapeutics Earnings and Revenue History